α-Enolase–binding peptide enhances drug delivery efficiency and therapeutic efficacy against colorectal cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
α-Enolase–binding peptide enhances drug delivery efficiency and therapeutic efficacy against colorectal cancer
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 7, Issue 290, Pages 290ra91-290ra91
Publisher
American Association for the Advancement of Science (AAAS)
Online
2015-06-04
DOI
10.1126/scitranslmed.aaa9391
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
- (2013) Roy van der Meel et al. ADVANCED DRUG DELIVERY REVIEWS
- Combinatorial Peptide Libraries: Mining for Cell-Binding Peptides
- (2013) Bethany Powell Gray et al. CHEMICAL REVIEWS
- Trastuzumab emtansine (T-DM1) for HER2-positive breast cancer
- (2013) Baris Boyraz et al. CURRENT MEDICAL RESEARCH AND OPINION
- Maturing antibody–drug conjugate pipeline hits 30
- (2013) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Antibody–drug conjugates
- (2013) Rachel S. Zolot et al. NATURE REVIEWS DRUG DISCOVERY
- From Phage Display to Nanoparticle Delivery: Functionalizing Liposomes with Multivalent Peptides Improves Targeting to a Cancer Biomarker
- (2012) Bethany Powell Gray et al. BIOCONJUGATE CHEMISTRY
- α-Enolase, a Multifunctional Protein: Its Role on Pathophysiological Situations
- (2012) Àngels Díaz-Ramos et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Single chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery
- (2011) Ruei-Min Lu et al. BIOMATERIALS
- α-enolase: a promising therapeutic and diagnostic tumor target
- (2011) Michela Capello et al. FEBS Journal
- In vivo targeting of B-cell lymphoma with glycan ligands of CD22
- (2010) W. C. Chen et al. BLOOD
- Peptidic Tumor Targeting Agents: The Road from Phage Display Peptide Selections to Clinical Applications
- (2010) Kathlynn Brown CURRENT PHARMACEUTICAL DESIGN
- ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction
- (2010) Sen-Tien Tsai et al. EUROPEAN JOURNAL OF CANCER
- Circulating Autoantibodies to Phosphorylated α-Enolase are a Hallmark of Pancreatic Cancer
- (2010) Barbara Tomaino et al. JOURNAL OF PROTEOME RESEARCH
- Receptor Mediated Tumor Targeting: An Emerging Approach for Cancer Therapy
- (2010) Chandana Mohanty et al. Current Drug Delivery
- Increased expression of enolase α in human breast cancer confers tamoxifen resistance in human breast cancer cells
- (2009) Shih-Hsin Tu et al. BREAST CANCER RESEARCH AND TREATMENT
- Tumor-Targeted Nanomedicines: Enhanced Antitumor Efficacy In vivo of Doxorubicin-Loaded, Long-Circulating Liposomes Modified with Cancer-Specific Monoclonal Antibody
- (2009) T. A. ElBayoumi et al. CLINICAL CANCER RESEARCH
- Upregulation of glycolytic enzymes in proteins secreted from human colon cancer cells with 5-fluorouracil resistance
- (2009) Young-Kyoung Shin et al. ELECTROPHORESIS
- Mouse Models of Colon Cancer
- (2009) Makoto Mark Taketo et al. GASTROENTEROLOGY
- An integrated humoral and cellular response is elicited in pancreatic cancer by α-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen
- (2009) Paola Cappello et al. INTERNATIONAL JOURNAL OF CANCER
- A Novel Peptide Enhances Therapeutic Efficacy of Liposomal Anti-Cancer Drugs in Mice Models of Human Lung Cancer
- (2009) De-Kuan Chang et al. PLoS One
- Hepatocellular carcinoma cell-specific peptide ligand for targeted drug delivery
- (2008) A. Lo et al. MOLECULAR CANCER THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now